A Comparative Study of New Medications for Psychosis in Adolescents
Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
The overall goal of this study is to determine the efficacy and tolerability of three
atypical antipsychotic medications (risperidone, olanzapine, and quetiapine) in the treatment
of adolescents with psychosis. It is hypothesized that the three medications will be equally
effective in reducing the symptoms of psychosis.
Phase:
N/A
Details
Lead Sponsor:
University of Minnesota University of Minnesota - Clinical and Translational Science Institute